The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/16365406

J. Immunol. 2006 Jan 1 176 1 157-64

Download in:

View as

General Info

PMID
16365406